Project description
Innovative stereoselective synthesis of alkene-containing compounds
Alkene-containing molecules and their derivatives are key ingredients in polymer science and materials research and are in high demand in medicine, food, and energy production. Most applications require alkenes and the derivatives to be present in isomerically pure form. Funded by the Marie Skłodowska Curie Actions programme, the TETRASYN project aims to develop a stereoselective synthesis of various tetrasubstituted alkenes from commercially available diboron compounds, using Cu based catalysts, nitriles and allenes. The resulting tetrasubstituted alkene products will contain modifiable functional groups and provide a source for a spectrum of derivatives. The objective is to prove the applicability of the approach via stereoselective synthesis of neocurcumenol, a natural anti inflammation medicine, and acolbifene, an experimental breast cancer treatment drug.
Objective
Alkene-containing molecules and their derivatives play a major role in medicine, food and energy production, as well as materials research and polymer science. In most applications, particularly in medicine, alkenes are needed in isomerically pure form. While strategies for stereoselective preparation of olefins have been the subject of substantial interest, methods relating to synthesis of tetrasubstituted alkenes are uncommon, especially those that are catalytic. What is more, the small number of available protocols are often not highly selective or broadly applicable. The goal of the proposed studies is to introduce a practical, scalable, modular and highly stereoselective synthesis of a large assortment tetrasubstituted alkenes from readily available Cu-based catalysts, nitriles, allenes, and a commercially available diboron compound. The tetrasubstituted alkene products will contain readily modifiable functional groups, such as a ketone, an ester, and a boronate moiety, thus offering direct access to a larger collection of otherwise difficult-to-prepare and much sought-after derivatives. The applicability of the approach will be highlighted by a concise and practical gram-scale stereoselective synthesis of two important bioactive compounds. The first will be neocurcumenol, a natural product with anti-inflammatory properties, and the second will be acolbifene, currently in third phase clinical trials for treatment of breast cancer. Equally important, the versatility of the catalytic strategy will allow for facile preparation of host of related analogues – entities that might display superior pharmacological properties and cannot be synthesized easily by the available methods.
Fields of science (EuroSciVoc)
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.
- natural sciences chemical sciences organic chemistry ketones
- natural sciences chemical sciences polymer sciences
- medical and health sciences clinical medicine oncology
- natural sciences chemical sciences catalysis
You need to log in or register to use this function
We are sorry... an unexpected error occurred during execution.
You need to be authenticated. Your session might have expired.
Thank you for your feedback. You will soon receive an email to confirm the submission. If you have selected to be notified about the reporting status, you will also be contacted when the reporting status will change.
Keywords
Project’s keywords as indicated by the project coordinator. Not to be confused with the EuroSciVoc taxonomy (Fields of science)
Project’s keywords as indicated by the project coordinator. Not to be confused with the EuroSciVoc taxonomy (Fields of science)
Programme(s)
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
-
H2020-EU.1.3. - EXCELLENT SCIENCE - Marie Skłodowska-Curie Actions
MAIN PROGRAMME
See all projects funded under this programme -
H2020-EU.1.3.2. - Nurturing excellence by means of cross-border and cross-sector mobility
See all projects funded under this programme
Topic(s)
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Funding Scheme
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
MSCA-IF - Marie Skłodowska-Curie Individual Fellowships (IF)
See all projects funded under this funding scheme
Call for proposal
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
(opens in new window) H2020-MSCA-IF-2020
See all projects funded under this callCoordinator
Net EU financial contribution. The sum of money that the participant receives, deducted by the EU contribution to its linked third party. It considers the distribution of the EU financial contribution between direct beneficiaries of the project and other types of participants, like third-party participants.
67081 STRASBOURG
France
The total costs incurred by this organisation to participate in the project, including direct and indirect costs. This amount is a subset of the overall project budget.